Causes and Risk Factors
In Graves' disease, an antibody called thyroid-stimulating immunoglobulin mimics the body's normal thyroid-stimulating hormone, driving the gland to make far too much hormone. Risk factors include:- Family history: Graves' disease and other thyroid conditions run in families.
- Sex: Women are affected several times more often than men.
- Other autoimmune diseases: Type 1 diabetes and rheumatoid arthritis increase the risk.
- Smoking and stress: Smoking in particular raises the risk of Graves' eye disease, and quitting is a treatment in itself.
- Pregnancy: Onset is somewhat more common in the year after delivery in susceptible women.
Symptoms
Symptoms reflect a metabolism running too fast and may include:- Unintentional weight loss: Despite a normal or increased appetite.
- Rapid or irregular heartbeat: Palpitations are common, and some people develop atrial fibrillation.
- Anxiety, irritability, and tremor: Along with difficulty sleeping.
- Heat intolerance and sweating: Feeling overheated when others are comfortable.
- Frequent bowel movements, muscle weakness, and an enlarged thyroid (goiter).
- Light or missed menstrual periods: Hormone excess commonly disrupts the menstrual cycle.
- Eye changes: In Graves' eye disease, the eyes may bulge, feel gritty, water, or see double; severe cases threaten vision and need prompt specialty care.
Diagnosis
Blood tests show a suppressed thyroid-stimulating hormone (TSH) with elevated thyroid hormone levels (T4 and T3), and measuring the stimulating antibody usually confirms Graves' disease as the cause. When the picture is unclear, a radioactive iodine uptake scan distinguishes Graves' disease from other causes of hyperthyroidism, such as thyroiditis or a hot nodule. Because anxiety, palpitations, and weight loss have many possible causes, hyperthyroidism is often discovered only when blood work is finally checked; labs are then repeated regularly during treatment to guide dosing.Treatment
Three effective options exist, and the choice depends on age, severity, eye involvement, and personal preference:- Antithyroid medication: Methimazole blocks hormone production and can bring about remission in some patients after one to two years of treatment.
- Beta-blockers: Used early on to control rapid heart rate, tremor, and anxiety while other treatment takes effect.
- Radioactive iodine: A capsule that gradually shrinks the overactive gland; most patients eventually develop hypothyroidism afterward and take thyroid hormone replacement.
- Surgery: Removing the thyroid is preferred for very large goiters, suspicious nodules, or when other options are unsuitable.
Living With Graves' Disease
Graves' disease is an autoimmune condition in which antibodies stimulate the thyroid to overproduce hormone. Unlike many autoimmune diseases it is highly treatable, and most people reach a stable, well-controlled state — but the path there involves a genuine choice between three approaches, and understanding the trade-offs makes that decision considerably easier.
Three routes, and why the choice is personal
Antithyroid medication offers the possibility of remission without permanently altering the gland, at the cost of twelve to eighteen months of treatment and a real chance of relapse afterwards. Radioiodine is definitive and straightforward but usually results in permanent hypothyroidism requiring lifelong replacement. Surgery is immediate and definitive but carries operative risk. None is obviously best, and factors including age, goitre size, eye involvement, pregnancy plans, and personal preference all legitimately shift the decision.
Why treatment takes weeks to work
Antithyroid drugs block hormone synthesis but do nothing to hormone already stored in the gland, and the thyroid holds several weeks of supply. Improvement usually begins after two to four weeks and full effect takes longer. A beta blocker is generally given alongside at the start because it controls palpitations, tremor, and anxiety within hours, which makes the waiting period tolerable. Patients not told this frequently conclude the treatment has failed.
The eyes are a separate problem
Thyroid eye disease follows its own course and does not necessarily improve when the thyroid is controlled. Gritty, watery, bulging, or double-visioned eyes warrant ophthalmology assessment, and smoking dramatically worsens it — stopping is the single most effective intervention available. Radioiodine can aggravate active eye disease, which is one of the clearest reasons to choose a different route. Our endocrine team manages these decisions alongside hyperthyroidism generally, and the thyroid testing guide covers who warrants screening. The American Thyroid Association and NIDDK both publish detailed patient guidance.
Pregnancy changes the plan
Untreated hyperthyroidism in pregnancy carries real risk, so stopping treatment is not the answer — but the choice of drug changes. Propylthiouracil is preferred in the first trimester because methimazole carries a specific malformation risk, with a switch back afterwards. Anyone of childbearing potential should know this before starting rather than at a first prenatal visit, and should make contact as soon as pregnancy is suspected.
To discuss which treatment route fits your situation, or to review thyroid levels that are not settling, schedule a visit.